
American Samoa On Alert After Imported Dengue Fever Cases Confirmed
The department said the disease was found in travelers who had recently returned from Samoa.
In its statement on Tuesday local time (Wednesday, NZT) it said there were no confirmed locally-acquired cases.
"While there is no confirmed local transmission in American Samoa at this time, the presence of dengue in travellers returning from these affected countries increases the risk of the virus being introduced and spread locally by mosquitoes."
Environmental spraying and monitoring have been underway at the affected residences and surrounding areas.
The health department has issued advice for travellers, including that those who have recently traveled to Samoa, Fiji, Tonga or other dengue-affected areas should monitor their health for 14 days upon return.
"Be alert for symptoms such as fever, rash, body aches, headache, or nausea. Seek medical care immediately if you develop symptoms and inform your physician of any travel history."
Samoa, Fiji and Tonga all declared dengue outbreaks earlier this year.
In its latest numbers released on 27 June, Tonga's dengue number had reached 884.
Samoa's Ministry of Health is posting on social media to remind people "dengue fever hasn't gone away" and offering advice.
It said Aedes mosquitoes are most active during early morning (6am-8am) and evening hours (4pm - 6pm).
"We can all prevent the spread of dengue by following easy preventative measures, such as wearing long sleeved clothes, remove all breeding sites, use repellent and mosquito net."
Health and climate
Meanwhile, the Federated States of Micronesia (FSM) has developed a major climate change and health programme aimed at preventing the spread of climate-sensitive diseases.
The SPC said illnesses from dengue fever to diarrhoea, once considered seasonal, are now becoming year-round threats, driven by rising temperatures, saltwater intrusion, and failing water and sanitation systems.
The project is backed by a US$17.9 million grant from the Green Climate Fund and delivered in partnership with the Pacific Community (SPC).
SPC said over the next five years, more than 78,000 people will benefit directly from improved disease surveillance and early warning systems, better access to health information, and resilient water and sanitation infrastructure.
Director of SPC's climate change and sustainability division, Coral Pasisi, said this addresses one of the Pacific's most pressing but underfunded challenges - the intersection between health and climate.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scoop
3 hours ago
- Scoop
Ozempic And Wegovy: The Pros And Cons, Explained
Earlier this week semaglutide drugs Ozempic and Wegovy were made available for prescription in New Zealand. Semaglutide originally arrived on the market in the US in 2017 as a diabetes medication, but has quickly been tied to extreme weight loss. Wegovy can be prescribed to people over the age of 12, but many of the 65 percent of New Zealanders who are overweight or obese will have trouble affording it, with an estimated price of $500 a month. The drugs have transformed our ability to manage obesity and type 2 diabetes, and have shown potential for a wide range of conditions such as Alzheimer's, addiction and depression. But there are clouds to go along with the silver linings - such as potential vision loss. "This condition, it occurs when there's insufficient blood flow to the nerves connecting the eye to the brain, and this leads to damage," US-based health reporter for New Scientist, Grace Wade, told RNZ's Sunday Morning. The specific condition was non-arteritic anterior ischemic optic neuropathy. "That can cause this sudden and permanent vision loss, usually in just one eye. Now, I should be clear this isn't total vision loss, at least usually - it's more like cloudiness, stuff like that." People using semaglutides to treat diabetes were 4.3 times more likely to develop this condition, and those using it for weight loss 7.6 times, as people using other types of diabetes medications, a 2024 study found (Wade wrote about it in New Scientist here). The drugs work by suppressing appetite, which typically leads to weight loss as people consume fewer calories. But the weight lost was not always beneficial, Wade said. "It leads the body to break down fat, muscle and actually even bone for nutrients, and that's why… some research has found that upwards of 40 percent of the weight loss seen with these medications is due to loss of muscle mass… that makes it really important that people prioritise exercise when taking these drugs because if you don't use your muscle, you're more likely to lose it." Getting into the exercise habit was also important since one day, most people on Ozempic or Wegovy will stop taking it - putting themselves at risk of putting the weight back on if they were not regularly moving. Then there is 'Ozempic face'. "I don't think this is a clinical term yet, but it's something that's popped up a lot in social media," Wade said. "People who are taking these medications start developing... a sunken or hollowed out appearance, which can exacerbate fine lines and wrinkles, make their skin look a little more saggy. "It isn't clear exactly how common this is… but it probably has to do with just weight loss, right? If you're losing weight, as much as some people would want to target their weight loss to certain areas of their body, we can't really do that. So, you know, any sort of overall weight loss is also gonna cause a loss of fat in your face." There were also side effects for some, including constantly needing to go to the toilet, feeling bloated, belching, constipation, heartburn, fever, upset stomach - the list, collected here by the Mayo Clinic, goes on. And nearly half of people who try it make it through a three-month course, one study found. Wade also mentioned a lot of people taking semaglutide for diabetes or Alzheimer's prevention might be older and "frail", so not able to lose weight. "Drug developers are actually working to develop new drugs that have similar effects as these weight loss medications, but without the weight loss." The good news One unexpected benefit of semaglutide was its apparent effect on not just calorie consumption, but use of addictive substances, such as alcohol and nicotine. "We aren't exactly sure why that is, but it appears to be with how these medications affect brain activity. "So these drugs curb cravings for alcohol similar to how they curb cravings for food, right? And that probably has to do with their impact on brain regions involved in reward processing and craving… "A study of more than half-a-million people with a history of opioid use disorders showed that those who took Ozempic or similar [medications] had significantly lower rates of opioid overdose than those who didn't. "Other studies have shown similar effects in people with cannabis use disorder, cigarette smokers and alcoholism." Scientists did not expect this effect, calling it an "unintended consequence". The drugs have also shown promise in reducing heart attacks and strokes, improving fertility, treating pain, improving mental health, lower the risk of kidney failure and slowing cognitive decline. "I've never encountered a group of drugs like this," Wade said. "That's what makes these drugs so remarkable, because most medications can only treat one or two conditions, right?" She said it was likely that weight loss was playing a role - as it frequently does in health - but "it doesn't seem to be the only [reason]". But there is still a lot of research to be done, she said, before we all start taking it. "Let's unravel how they can treat all of these conditions before we jump the gun and start suggesting we, you know, maybe put it in everyone's water or something."


Scoop
2 days ago
- Scoop
American Samoa On Alert After Imported Dengue Fever Cases Confirmed
The territory's health department says the disease was found in travelers who recently returned from Samoa. RNZ Pacific The American Samoa Department of Health has issued a travel health alert after confirmation of three imported cases of dengue fever. The department said the disease was found in travelers who had recently returned from Samoa. In its statement on Tuesday local time (Wednesday, NZT) it said there were no confirmed locally-acquired cases. 'While there is no confirmed local transmission in American Samoa at this time, the presence of dengue in travellers returning from these affected countries increases the risk of the virus being introduced and spread locally by mosquitoes.' Environmental spraying and monitoring have been underway at the affected residences and surrounding areas. The health department has issued advice for travellers, including that those who have recently traveled to Samoa, Fiji, Tonga or other dengue-affected areas should monitor their health for 14 days upon return. 'Be alert for symptoms such as fever, rash, body aches, headache, or nausea. Seek medical care immediately if you develop symptoms and inform your physician of any travel history.' Samoa, Fiji and Tonga all declared dengue outbreaks earlier this year. In its latest numbers released on 27 June, Tonga's dengue number had reached 884. Samoa's Ministry of Health is posting on social media to remind people 'dengue fever hasn't gone away' and offering advice. It said Aedes mosquitoes are most active during early morning (6am-8am) and evening hours (4pm – 6pm). 'We can all prevent the spread of dengue by following easy preventative measures, such as wearing long sleeved clothes, remove all breeding sites, use repellent and mosquito net.' Health and climate Meanwhile, the Federated States of Micronesia (FSM) has developed a major climate change and health programme aimed at preventing the spread of climate-sensitive diseases. The SPC said illnesses from dengue fever to diarrhoea, once considered seasonal, are now becoming year-round threats, driven by rising temperatures, saltwater intrusion, and failing water and sanitation systems. The project is backed by a US$17.9 million grant from the Green Climate Fund and delivered in partnership with the Pacific Community (SPC). SPC said over the next five years, more than 78,000 people will benefit directly from improved disease surveillance and early warning systems, better access to health information, and resilient water and sanitation infrastructure. Director of SPC's climate change and sustainability division, Coral Pasisi, said this addresses one of the Pacific's most pressing but underfunded challenges – the intersection between health and climate.


Scoop
2 days ago
- Scoop
American Samoa On Alert After Imported Dengue Fever Cases Confirmed
The American Samoa Department of Health has issued a travel health alert after confirmation of three imported cases of dengue fever. The department said the disease was found in travelers who had recently returned from Samoa. In its statement on Tuesday local time (Wednesday, NZT) it said there were no confirmed locally-acquired cases. "While there is no confirmed local transmission in American Samoa at this time, the presence of dengue in travellers returning from these affected countries increases the risk of the virus being introduced and spread locally by mosquitoes." Environmental spraying and monitoring have been underway at the affected residences and surrounding areas. The health department has issued advice for travellers, including that those who have recently traveled to Samoa, Fiji, Tonga or other dengue-affected areas should monitor their health for 14 days upon return. "Be alert for symptoms such as fever, rash, body aches, headache, or nausea. Seek medical care immediately if you develop symptoms and inform your physician of any travel history." Samoa, Fiji and Tonga all declared dengue outbreaks earlier this year. In its latest numbers released on 27 June, Tonga's dengue number had reached 884. Samoa's Ministry of Health is posting on social media to remind people "dengue fever hasn't gone away" and offering advice. It said Aedes mosquitoes are most active during early morning (6am-8am) and evening hours (4pm - 6pm). "We can all prevent the spread of dengue by following easy preventative measures, such as wearing long sleeved clothes, remove all breeding sites, use repellent and mosquito net." Health and climate Meanwhile, the Federated States of Micronesia (FSM) has developed a major climate change and health programme aimed at preventing the spread of climate-sensitive diseases. The SPC said illnesses from dengue fever to diarrhoea, once considered seasonal, are now becoming year-round threats, driven by rising temperatures, saltwater intrusion, and failing water and sanitation systems. The project is backed by a US$17.9 million grant from the Green Climate Fund and delivered in partnership with the Pacific Community (SPC). SPC said over the next five years, more than 78,000 people will benefit directly from improved disease surveillance and early warning systems, better access to health information, and resilient water and sanitation infrastructure. Director of SPC's climate change and sustainability division, Coral Pasisi, said this addresses one of the Pacific's most pressing but underfunded challenges - the intersection between health and climate.